Gene therapy. Questions remain on cause of death in arthritis trial.
Kaiser
Jocelyn
J
D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D002423:Cause of Death; D005260:Female; D015316:Genetic Therapy / Q000009:adverse effects*; D006658:Histoplasma; D006660:Histoplasmosis / Q000276:immunology / Q000401:mortality; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab